SoftGroup has released its Sustainability Report for 2025, outlining the company’s progress and commitments across environmental, social, and governance (ESG) areas.
The report reflects a structured approach to sustainability, aligned with internationally recognized frameworks and supported by measurable actions across the organization.
A structured approach to responsible growth
Throughout 2025, SoftGroup continued to strengthen its internal policies and operational practices, focusing on:
- responsible business conduct and ethical standards
- employee development and workplace conditions
- environmental impact and resource efficiency
- secure and compliant technology operations
Focus on people and expertise
SoftGroup invests consistently in employee development, with structured training programs covering both technical and ESG-related topics.
This supports the company’s long-term objective to build expertise not only in pharmaceutical serialization and traceability, but also in responsible business practices.
Operational responsibility in a regulated industry
Operating in highly regulated pharmaceutical environments, SoftGroup integrates sustainability with its core mission: ensuring reliable, secure, and compliant data exchange across global supply chains.
The company’s technology and processes are designed to support transparency, data integrity, and long-term operational resilience for its customers and partners.
Continuous improvement and external evaluation
In 2025, SoftGroup continued its engagement with external sustainability assessment frameworks, including EcoVadis, as part of its commitment to continuous improvement and transparency.
The Sustainability Report 2025 provides a clear overview of current practices and outlines the company’s direction for further development in the coming years.
